Literature DB >> 2744400

Infravesical outflow obstruction in rats: a comparison of two models.

C A Maggi1, S Manzini, S Giuliani, A Meli.   

Abstract

1. A new model of infravesical outflow obstruction was developed in male rats by the repeated s.c. administration of testosterone for 5-15 days (3 mg/kg die). The effects of this treatment which produced a 65% increase of prostate weight (10 days) on bladder voiding was evaluated in urethane anesthetized rats by the transvesical infusion of saline and compared to the cystometric alterations produced by application of a silk ligature at urethral level in female rats (4-8 weeks before) as described by Malmgren et al. (1987a, b). 2. Testosterone-pretreatment for 10 days produced little changes in bladder weight, bladder capacity or amplitude of micturition contraction but determined a marked increase in residual volume, indicating that infravesical outflow obstruction impaired significantly bladder voiding. Furthermore, detrusor instability was observed in the majority of testosterone-treated rats. 3. The participation of an active component to voiding impairment in testosterone-treated rats was suggested by the effect of intravenous prazosin which improved voiding efficiency. 4. In urethra-ligated female rats there was a marked increase in bladder weight which was paralleled by a dramatic alteration in micturition reflex that is marked increase in bladder capacity and residual volume. 5. It is concluded that these two models of infravesical outflow obstruction produce cystometric patterns simulating the urodynamic alterations observed in patients with benign prostatic hyperplasia and are potentially suitable for development of drugs in this field.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2744400     DOI: 10.1016/0306-3623(89)90271-1

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  16 in total

1.  Vascular response of the rabbit bladder to chronic partial outlet obstruction.

Authors:  P Chichester; A Schröder; P Horan; R M Levin
Journal:  Mol Cell Biochem       Date:  2001-10       Impact factor: 3.396

2.  Vascular response of the rabbit bladder to short term partial outlet obstruction.

Authors:  P Chichester; J Lieb; S S Levin; R Buttyan; P Horan; R M Levin
Journal:  Mol Cell Biochem       Date:  2000-05       Impact factor: 3.396

3.  Effect of orchiectomy and testosterone replacement on lower urinary tract function in anesthetized rats.

Authors:  Chen-Li Cheng; William C de Groat
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-17

4.  Bawu decoction () ameliorates benign prostatic hyperplasia in rats.

Authors:  Ji-Hwan Eom; Se-Yun Cheon; Kyung-Sook Chung; Myung-Dong Kim; Hyo-Jin An
Journal:  Chin J Integr Med       Date:  2016-11-12       Impact factor: 1.978

5.  Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia.

Authors:  Ferenc G Rick; Andrew V Schally; Norman L Block; Mehrdad Nadji; Karoly Szepeshazi; Marta Zarandi; Irving Vidaurre; Roberto Perez; Gabor Halmos; Luca Szalontay
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-14       Impact factor: 11.205

6.  Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist.

Authors:  Ferenc G Rick; Andrew Abi-Chaker; Luca Szalontay; Roberto Perez; Miklos Jaszberenyi; Arumugam R Jayakumar; Nagarajarao Shamaladevi; Karoly Szepeshazi; Irving Vidaurre; Gabor Halmos; Awtar Krishan; Norman L Block; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

7.  Modulatory effect of silymarin on inflammatory mediators in experimentally induced benign prostatic hyperplasia: emphasis on PTEN, HIF-1α, and NF-κB.

Authors:  Reem T Atawia; Hala H Mosli; Mariane G Tadros; Amani E Khalifa; Hisham A Mosli; Ashraf B Abdel-Naim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-08-28       Impact factor: 3.000

8.  Musulju improves benign prostatic hyperplasia by regulating inflammatory and apoptotic proteins.

Authors:  Jae-Yun Ju; Kyung-Sook Chung; Se-Yun Cheon; Hyo-Jin An
Journal:  Mol Med Rep       Date:  2016-10-12       Impact factor: 2.952

9.  Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase.

Authors:  Hyun-Myung Choi; Yunu Jung; Jinbong Park; Hye-Lin Kim; Dong-Hyun Youn; JongWook Kang; Mi-Young Jeong; Jong-Hyun Lee; Woong Mo Yang; Seok-Geun Lee; Kwang Seok Ahn; Jae-Young Um
Journal:  Sci Rep       Date:  2016-08-23       Impact factor: 4.379

10.  Metformin Attenuates Testosterone-Induced Prostatic Hyperplasia in Rats: A Pharmacological Perspective.

Authors:  Hala H Mosli; Ahmed Esmat; Reem T Atawia; Sherif M Shoieb; Hisham A Mosli; Ashraf B Abdel-Naim
Journal:  Sci Rep       Date:  2015-10-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.